

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | thyroid hormone generation (GO:0006590) | 9.46648151 |
| 2 | regulation of clathrin-mediated endocytosis (GO:2000369) | 8.09166773 |
| 3 | thyroid hormone metabolic process (GO:0042403) | 7.89190014 |
| 4 | fusion of sperm to egg plasma membrane (GO:0007342) | 7.40469861 |
| 5 | regulation of acrosome reaction (GO:0060046) | 7.36682802 |
| 6 | positive regulation of antigen processing and presentation (GO:0002579) | 7.24168875 |
| 7 | seminiferous tubule development (GO:0072520) | 6.50255826 |
| 8 | regulation of antigen processing and presentation (GO:0002577) | 5.75967782 |
| 9 | plasma membrane fusion (GO:0045026) | 5.62473674 |
| 10 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 4.98874015 |
| 11 | complement activation, alternative pathway (GO:0006957) | 4.81870583 |
| 12 | response to parathyroid hormone (GO:0071107) | 4.70752773 |
| 13 | sulfur amino acid catabolic process (GO:0000098) | 4.68596320 |
| 14 | kynurenine metabolic process (GO:0070189) | 4.51466223 |
| 15 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.22420574 |
| 16 | macroautophagy (GO:0016236) | 4.14351348 |
| 17 | regulation of T cell tolerance induction (GO:0002664) | 4.11714513 |
| 18 | regulation of Cdc42 GTPase activity (GO:0043088) | 3.84466536 |
| 19 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.76594251 |
| 20 | valine metabolic process (GO:0006573) | 3.66186651 |
| 21 | cellular sodium ion homeostasis (GO:0006883) | 3.65449202 |
| 22 | thyroid gland development (GO:0030878) | 3.55931091 |
| 23 | cysteine metabolic process (GO:0006534) | 3.51039095 |
| 24 | positive regulation of tolerance induction (GO:0002645) | 3.46011870 |
| 25 | tryptophan catabolic process (GO:0006569) | 3.34373170 |
| 26 | indole-containing compound catabolic process (GO:0042436) | 3.34373170 |
| 27 | indolalkylamine catabolic process (GO:0046218) | 3.34373170 |
| 28 | negative regulation of endopeptidase activity (GO:0010951) | 3.31947408 |
| 29 | alpha-linolenic acid metabolic process (GO:0036109) | 3.28182160 |
| 30 | response to misfolded protein (GO:0051788) | 3.26239444 |
| 31 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 3.21147903 |
| 32 | negative regulation of peptidase activity (GO:0010466) | 3.17877590 |
| 33 | negative regulation of metanephros development (GO:0072217) | 3.13303431 |
| 34 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 3.12604722 |
| 35 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.10559811 |
| 36 | ethanol oxidation (GO:0006069) | 3.08140749 |
| 37 | eye photoreceptor cell differentiation (GO:0001754) | 2.99019791 |
| 38 | photoreceptor cell differentiation (GO:0046530) | 2.99019791 |
| 39 | tryptophan metabolic process (GO:0006568) | 2.92087777 |
| 40 | regulation of tolerance induction (GO:0002643) | 2.91191063 |
| 41 | sodium ion homeostasis (GO:0055078) | 2.91034172 |
| 42 | metanephric tubule development (GO:0072170) | 2.88824464 |
| 43 | metanephric nephron tubule development (GO:0072234) | 2.88824464 |
| 44 | drug transmembrane transport (GO:0006855) | 2.87260470 |
| 45 | benzene-containing compound metabolic process (GO:0042537) | 2.86802779 |
| 46 | organic cation transport (GO:0015695) | 2.85642877 |
| 47 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.79755593 |
| 48 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 2.77187623 |
| 49 | hydrogen peroxide catabolic process (GO:0042744) | 2.76692942 |
| 50 | negative regulation of protein autophosphorylation (GO:0031953) | 2.74616889 |
| 51 | sperm capacitation (GO:0048240) | 2.74573968 |
| 52 | cytolysis (GO:0019835) | 2.72428901 |
| 53 | aromatic amino acid family catabolic process (GO:0009074) | 2.72154977 |
| 54 | response to lead ion (GO:0010288) | 2.69665706 |
| 55 | cellular modified amino acid catabolic process (GO:0042219) | 2.65936556 |
| 56 | metanephric nephron epithelium development (GO:0072243) | 2.65390728 |
| 57 | response to nitrosative stress (GO:0051409) | 2.63648391 |
| 58 | regulation of complement activation (GO:0030449) | 2.60667538 |
| 59 | hypotonic response (GO:0006971) | 2.60172558 |
| 60 | quaternary ammonium group transport (GO:0015697) | 2.58681563 |
| 61 | nephron tubule formation (GO:0072079) | 2.57053878 |
| 62 | amino-acid betaine transport (GO:0015838) | 2.56211397 |
| 63 | carnitine transport (GO:0015879) | 2.56211397 |
| 64 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.53746911 |
| 65 | phosphate ion homeostasis (GO:0055062) | 2.49266161 |
| 66 | trivalent inorganic anion homeostasis (GO:0072506) | 2.49266161 |
| 67 | phospholipid homeostasis (GO:0055091) | 2.48078004 |
| 68 | tricarboxylic acid metabolic process (GO:0072350) | 2.47441222 |
| 69 | regulation of protein activation cascade (GO:2000257) | 2.46849730 |
| 70 | peptide catabolic process (GO:0043171) | 2.46690967 |
| 71 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.44781176 |
| 72 | negative regulation of endocytosis (GO:0045806) | 2.44164597 |
| 73 | nephron tubule development (GO:0072080) | 2.43957956 |
| 74 | drug transport (GO:0015893) | 2.42752012 |
| 75 | GPI anchor biosynthetic process (GO:0006506) | 2.42564400 |
| 76 | low-density lipoprotein particle clearance (GO:0034383) | 2.42412967 |
| 77 | phosphorelay signal transduction system (GO:0000160) | 2.41953930 |
| 78 | Golgi transport vesicle coating (GO:0048200) | 2.40385220 |
| 79 | COPI coating of Golgi vesicle (GO:0048205) | 2.40385220 |
| 80 | positive regulation of glycogen biosynthetic process (GO:0045725) | 2.37642591 |
| 81 | triglyceride catabolic process (GO:0019433) | 2.35636758 |
| 82 | fatty acid beta-oxidation (GO:0006635) | 2.35375513 |
| 83 | metanephric epithelium development (GO:0072207) | 2.34297557 |
| 84 | sulfate transmembrane transport (GO:1902358) | 2.33983432 |
| 85 | collecting duct development (GO:0072044) | 2.33956243 |
| 86 | branched-chain amino acid metabolic process (GO:0009081) | 2.33704222 |
| 87 | regulation of chronic inflammatory response (GO:0002676) | 2.32793593 |
| 88 | brown fat cell differentiation (GO:0050873) | 2.30359637 |
| 89 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 2.28475702 |
| 90 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.27887064 |
| 91 | GPI anchor metabolic process (GO:0006505) | 2.27279107 |
| 92 | mannose metabolic process (GO:0006013) | 2.27191109 |
| 93 | oxaloacetate metabolic process (GO:0006107) | 2.26260358 |
| 94 | regulation of lipoprotein metabolic process (GO:0050746) | 2.23753055 |
| 95 | negative regulation of proteolysis (GO:0045861) | 2.19935757 |
| 96 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 16.6982565 |
| 97 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 16.6982565 |
| 98 | antigen processing and presentation via MHC class Ib (GO:0002475) | 15.9315708 |
| 99 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 14.7690273 |
| 100 | antigen processing and presentation of endogenous antigen (GO:0019883) | 13.8637087 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.37330063 |
| 2 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.15219275 |
| 3 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.76306999 |
| 4 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.72061357 |
| 5 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.66024994 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.55522489 |
| 7 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.43768313 |
| 8 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.28745409 |
| 9 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.28231716 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.24572761 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.20191990 |
| 12 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.18513427 |
| 13 | GATA1_22025678_ChIP-Seq_K562_Human | 10.0322469 |
| 14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.87815663 |
| 15 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.59196933 |
| 16 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.56978344 |
| 17 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.45793859 |
| 18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.38482383 |
| 19 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.36297756 |
| 20 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.34797335 |
| 21 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.31844972 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.31703461 |
| 23 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.31294681 |
| 24 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.28712797 |
| 25 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.24564434 |
| 26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.24490644 |
| 27 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.24278445 |
| 28 | MYC_19915707_ChIP-ChIP_AK7_Human | 1.23256573 |
| 29 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.23146181 |
| 30 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.22201816 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.21912780 |
| 32 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.20484289 |
| 33 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18998864 |
| 34 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18757344 |
| 35 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.18657817 |
| 36 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.18488670 |
| 37 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.17429551 |
| 38 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.13087901 |
| 39 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.13068456 |
| 40 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.12068429 |
| 41 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.10333129 |
| 42 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08587428 |
| 43 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.08187993 |
| 44 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.04267510 |
| 45 | P68_20966046_ChIP-Seq_HELA_Human | 1.02716458 |
| 46 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.01066863 |
| 47 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.01066863 |
| 48 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.01005424 |
| 49 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.00715013 |
| 50 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.00180511 |
| 51 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00179271 |
| 52 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.98438725 |
| 53 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.97040460 |
| 54 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.95620676 |
| 55 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.94910909 |
| 56 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.94411293 |
| 57 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.94411293 |
| 58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94077769 |
| 59 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93680733 |
| 60 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93662942 |
| 61 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.92796960 |
| 62 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.92752269 |
| 63 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.91368976 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.91341505 |
| 65 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.90299838 |
| 66 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.89510790 |
| 67 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.89488505 |
| 68 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.89367189 |
| 69 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.87639755 |
| 70 | KDM2B_26808549_Chip-Seq_K562_Human | 0.87236148 |
| 71 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.87038792 |
| 72 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86705298 |
| 73 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.86219429 |
| 74 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.85128543 |
| 75 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.84464248 |
| 76 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83962172 |
| 77 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.83585259 |
| 78 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.83544381 |
| 79 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.83024165 |
| 80 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.82473144 |
| 81 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.82137837 |
| 82 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.82043555 |
| 83 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.81676067 |
| 84 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 0.81470385 |
| 85 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.80515402 |
| 86 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.79654654 |
| 87 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.79421208 |
| 88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.78986296 |
| 89 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.78590258 |
| 90 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.78486421 |
| 91 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.78186467 |
| 92 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.77984239 |
| 93 | FLI1_21867929_ChIP-Seq_CD8_Mouse | 0.75942725 |
| 94 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.75114005 |
| 95 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.74948307 |
| 96 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.74246952 |
| 97 | SMAD4_21741376_ChIP-Seq_ESCs_Human | 0.74137194 |
| 98 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.73966332 |
| 99 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.73877963 |
| 100 | CJUN_26792858_Chip-Seq_BT549_Human | 0.72754603 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 5.11769797 |
| 2 | MP0004043_abnormal_pH_regulation | 4.64112039 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.93783339 |
| 4 | MP0000681_abnormal_thyroid_gland | 3.71763260 |
| 5 | MP0003195_calcinosis | 3.19578228 |
| 6 | MP0010234_abnormal_vibrissa_follicle | 2.95498500 |
| 7 | MP0010678_abnormal_skin_adnexa | 2.55886934 |
| 8 | MP0005360_urolithiasis | 2.48682617 |
| 9 | MP0002876_abnormal_thyroid_physiology | 2.45680702 |
| 10 | MP0002138_abnormal_hepatobiliary_system | 2.42801134 |
| 11 | MP0000383_abnormal_hair_follicle | 2.42487480 |
| 12 | MP0005377_hearing/vestibular/ear_phenot | 2.29828590 |
| 13 | MP0003878_abnormal_ear_physiology | 2.29828590 |
| 14 | MP0003300_gastrointestinal_ulcer | 2.25801665 |
| 15 | MP0009643_abnormal_urine_homeostasis | 2.24864862 |
| 16 | MP0005670_abnormal_white_adipose | 2.17348976 |
| 17 | MP0001765_abnormal_ion_homeostasis | 2.16101362 |
| 18 | MP0001756_abnormal_urination | 2.05052025 |
| 19 | MP0000678_abnormal_parathyroid_gland | 2.03940403 |
| 20 | MP0004019_abnormal_vitamin_homeostasis | 2.02815387 |
| 21 | MP0005666_abnormal_adipose_tissue | 2.02002085 |
| 22 | MP0005332_abnormal_amino_acid | 1.86395181 |
| 23 | MP0005375_adipose_tissue_phenotype | 1.85999094 |
| 24 | MP0005636_abnormal_mineral_homeostasis | 1.85794241 |
| 25 | MP0003705_abnormal_hypodermis_morpholog | 1.85189667 |
| 26 | MP0008438_abnormal_cutaneous_collagen | 1.84347374 |
| 27 | MP0004185_abnormal_adipocyte_glucose | 1.83953028 |
| 28 | MP0002254_reproductive_system_inflammat | 1.78844856 |
| 29 | MP0000003_abnormal_adipose_tissue | 1.69571756 |
| 30 | MP0010329_abnormal_lipoprotein_level | 1.63714084 |
| 31 | MP0005365_abnormal_bile_salt | 1.61050122 |
| 32 | MP0003191_abnormal_cellular_cholesterol | 1.55491439 |
| 33 | MP0005275_abnormal_skin_tensile | 1.55310147 |
| 34 | MP0004130_abnormal_muscle_cell | 1.52344831 |
| 35 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.49063102 |
| 36 | MP0002168_other_aberrant_phenotype | 1.48567934 |
| 37 | MP0003303_peritoneal_inflammation | 1.46978843 |
| 38 | MP0002136_abnormal_kidney_physiology | 1.46749392 |
| 39 | MP0010386_abnormal_urinary_bladder | 1.39796978 |
| 40 | MP0008995_early_reproductive_senescence | 1.38250131 |
| 41 | MP0003566_abnormal_cell_adhesion | 1.33332107 |
| 42 | MP0008875_abnormal_xenobiotic_pharmacok | 1.31838226 |
| 43 | MP0003252_abnormal_bile_duct | 1.31128626 |
| 44 | MP0002118_abnormal_lipid_homeostasis | 1.28474626 |
| 45 | MP0001958_emphysema | 1.27285480 |
| 46 | MP0004264_abnormal_extraembryonic_tissu | 1.20446782 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.20300483 |
| 48 | MP0002837_dystrophic_cardiac_calcinosis | 1.17407520 |
| 49 | MP0002796_impaired_skin_barrier | 1.17328744 |
| 50 | MP0004885_abnormal_endolymph | 1.15480102 |
| 51 | MP0004858_abnormal_nervous_system | 1.14866156 |
| 52 | MP0002896_abnormal_bone_mineralization | 1.14814963 |
| 53 | MP0002653_abnormal_ependyma_morphology | 1.13842126 |
| 54 | MP0003879_abnormal_hair_cell | 1.12649029 |
| 55 | MP0004036_abnormal_muscle_relaxation | 1.11315946 |
| 56 | MP0004272_abnormal_basement_membrane | 1.11276473 |
| 57 | MP0005085_abnormal_gallbladder_physiolo | 1.09139407 |
| 58 | MP0005410_abnormal_fertilization | 1.07678482 |
| 59 | MP0000462_abnormal_digestive_system | 1.02793643 |
| 60 | MP0003075_altered_response_to | 1.01501228 |
| 61 | MP0009384_cardiac_valve_regurgitation | 0.94831740 |
| 62 | MP0005319_abnormal_enzyme/_coenzyme | 0.93174163 |
| 63 | MP0000538_abnormal_urinary_bladder | 0.92984549 |
| 64 | MP0000609_abnormal_liver_physiology | 0.91170174 |
| 65 | MP0002295_abnormal_pulmonary_circulatio | 0.91071568 |
| 66 | MP0000534_abnormal_ureter_morphology | 0.89829752 |
| 67 | MP0003172_abnormal_lysosome_physiology | 0.89075821 |
| 68 | MP0003045_fibrosis | 0.87749618 |
| 69 | MP0009763_increased_sensitivity_to | 0.87566940 |
| 70 | MP0001501_abnormal_sleep_pattern | 0.86640009 |
| 71 | MP0003690_abnormal_glial_cell | 0.85039771 |
| 72 | MP0002234_abnormal_pharynx_morphology | 0.83963273 |
| 73 | MP0001666_abnormal_nutrient_absorption | 0.83887903 |
| 74 | MP0008004_abnormal_stomach_pH | 0.83494735 |
| 75 | MP0004084_abnormal_cardiac_muscle | 0.81011653 |
| 76 | MP0003329_amyloid_beta_deposits | 0.80631834 |
| 77 | MP0000537_abnormal_urethra_morphology | 0.79358315 |
| 78 | MP0002971_abnormal_brown_adipose | 0.77942011 |
| 79 | MP0005395_other_phenotype | 0.77137104 |
| 80 | MP0000230_abnormal_systemic_arterial | 0.74271220 |
| 81 | MP0009115_abnormal_fat_cell | 0.74259237 |
| 82 | MP0003638_abnormal_response/metabolism_ | 0.72198952 |
| 83 | MP0005408_hypopigmentation | 0.72143291 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 0.71900998 |
| 85 | MP0002135_abnormal_kidney_morphology | 0.71363670 |
| 86 | MP0003186_abnormal_redox_activity | 0.68709562 |
| 87 | MP0008961_abnormal_basal_metabolism | 0.68227762 |
| 88 | MP0000604_amyloidosis | 0.67228569 |
| 89 | MP0005381_digestive/alimentary_phenotyp | 0.66717003 |
| 90 | MP0003806_abnormal_nucleotide_metabolis | 0.64923327 |
| 91 | MP0001177_atelectasis | 0.63665099 |
| 92 | MP0003953_abnormal_hormone_level | 0.62034159 |
| 93 | MP0005535_abnormal_body_temperature | 0.61067029 |
| 94 | MP0003183_abnormal_peptide_metabolism | 0.61010161 |
| 95 | MP0006138_congestive_heart_failure | 0.59291110 |
| 96 | MP0005310_abnormal_salivary_gland | 0.59009550 |
| 97 | MP0005334_abnormal_fat_pad | 0.58860972 |
| 98 | MP0010771_integument_phenotype | 0.52911048 |
| 99 | MP0005620_abnormal_muscle_contractility | 0.52536831 |
| 100 | MP0003795_abnormal_bone_structure | 0.51321763 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Goiter (HP:0000853) | 5.69111073 |
| 2 | Complement deficiency (HP:0004431) | 5.66380418 |
| 3 | Hyperphosphatemia (HP:0002905) | 5.26958442 |
| 4 | Choroideremia (HP:0001139) | 5.26075407 |
| 5 | Pili torti (HP:0003777) | 5.13917906 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 4.86528737 |
| 7 | Abnormality of the fovea (HP:0000493) | 4.83456660 |
| 8 | Thyroid-stimulating hormone excess (HP:0002925) | 4.53170234 |
| 9 | Potter facies (HP:0002009) | 4.43594048 |
| 10 | Facial shape deformation (HP:0011334) | 4.43594048 |
| 11 | Vascular calcification (HP:0004934) | 4.13020303 |
| 12 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.97962161 |
| 13 | Abnormality of complement system (HP:0005339) | 3.91288801 |
| 14 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.85201949 |
| 15 | Cardiovascular calcification (HP:0011915) | 3.83972180 |
| 16 | Proximal tubulopathy (HP:0000114) | 3.76673013 |
| 17 | Metaphyseal cupping (HP:0003021) | 3.74545611 |
| 18 | Hand muscle atrophy (HP:0009130) | 3.69444565 |
| 19 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.53671572 |
| 20 | Hyperglycinuria (HP:0003108) | 3.45878703 |
| 21 | Abnormal hair laboratory examination (HP:0003328) | 3.28684847 |
| 22 | Aplasia/Hypoplasia of the abdominal wall musculature (HP:0010318) | 3.23859557 |
| 23 | Tubulointerstitial fibrosis (HP:0005576) | 3.19067901 |
| 24 | Stridor (HP:0010307) | 3.16885609 |
| 25 | Upper limb amyotrophy (HP:0009129) | 3.14845385 |
| 26 | Distal upper limb amyotrophy (HP:0007149) | 3.14845385 |
| 27 | Hypopigmentation of the fundus (HP:0007894) | 3.04490059 |
| 28 | Hypophosphatemic rickets (HP:0004912) | 3.03594831 |
| 29 | Facial diplegia (HP:0001349) | 3.01382741 |
| 30 | Tetany (HP:0001281) | 2.98984393 |
| 31 | Abnormality of chloride homeostasis (HP:0011422) | 2.95902766 |
| 32 | Myocardial infarction (HP:0001658) | 2.93176058 |
| 33 | Abnormality of macular pigmentation (HP:0008002) | 2.91708380 |
| 34 | Action tremor (HP:0002345) | 2.87287150 |
| 35 | 11 pairs of ribs (HP:0000878) | 2.86002022 |
| 36 | Diaphragmatic weakness (HP:0009113) | 2.85124659 |
| 37 | Hyperactive renin-angiotensin system (HP:0000841) | 2.83983014 |
| 38 | Ketoacidosis (HP:0001993) | 2.83382532 |
| 39 | Cervical subluxation (HP:0003308) | 2.79700153 |
| 40 | Dysostosis multiplex (HP:0000943) | 2.77058678 |
| 41 | Mucopolysacchariduria (HP:0008155) | 2.73829695 |
| 42 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.73829695 |
| 43 | Abnormality of glycine metabolism (HP:0010895) | 2.73826440 |
| 44 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.73826440 |
| 45 | Intention tremor (HP:0002080) | 2.67845324 |
| 46 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.60970028 |
| 47 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.60970028 |
| 48 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.60970028 |
| 49 | Muscle fiber splitting (HP:0003555) | 2.54953462 |
| 50 | Central scotoma (HP:0000603) | 2.52432064 |
| 51 | Neurofibrillary tangles (HP:0002185) | 2.50672618 |
| 52 | Nonprogressive disorder (HP:0003680) | 2.45212028 |
| 53 | Focal segmental glomerulosclerosis (HP:0000097) | 2.43728952 |
| 54 | Hypokalemic alkalosis (HP:0001949) | 2.39395828 |
| 55 | Abnormality of purine metabolism (HP:0004352) | 2.36145819 |
| 56 | Hyperglycinemia (HP:0002154) | 2.35448134 |
| 57 | Malnutrition (HP:0004395) | 2.34718165 |
| 58 | Gout (HP:0001997) | 2.32518852 |
| 59 | Cerebral inclusion bodies (HP:0100314) | 2.31716429 |
| 60 | Rickets (HP:0002748) | 2.29245852 |
| 61 | Thin bony cortex (HP:0002753) | 2.22904181 |
| 62 | Aortic aneurysm (HP:0004942) | 2.22745753 |
| 63 | Ulnar deviation of the wrist (HP:0003049) | 2.19858164 |
| 64 | Ketosis (HP:0001946) | 2.18454451 |
| 65 | Onycholysis (HP:0001806) | 2.16533915 |
| 66 | Cone-rod dystrophy (HP:0000548) | 2.13585413 |
| 67 | Abnormality of the calcaneus (HP:0008364) | 2.13181295 |
| 68 | Infantile muscular hypotonia (HP:0008947) | 2.10593454 |
| 69 | Glomerulosclerosis (HP:0000096) | 2.08668843 |
| 70 | Bicornuate uterus (HP:0000813) | 2.08603326 |
| 71 | Abnormal hemoglobin (HP:0011902) | 2.07792308 |
| 72 | Delayed CNS myelination (HP:0002188) | 2.03046685 |
| 73 | Missing ribs (HP:0000921) | 2.02148772 |
| 74 | Polar cataract (HP:0010696) | 1.99569298 |
| 75 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.97084448 |
| 76 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.97084448 |
| 77 | Hyperaldosteronism (HP:0000859) | 1.94903265 |
| 78 | Agitation (HP:0000713) | 1.94713836 |
| 79 | Subcapsular cataract (HP:0000523) | 1.94011038 |
| 80 | Acanthosis nigricans (HP:0000956) | 1.89347144 |
| 81 | Aortic dissection (HP:0002647) | 1.88904885 |
| 82 | Hypophosphatemia (HP:0002148) | 1.88833227 |
| 83 | Progressive visual loss (HP:0000529) | 1.87598985 |
| 84 | Osteomalacia (HP:0002749) | 1.85741117 |
| 85 | Aplasia of the musculature (HP:0100854) | 1.84216244 |
| 86 | Metabolic alkalosis (HP:0200114) | 1.81047187 |
| 87 | Abnormality of renal excretion (HP:0011036) | 1.79198900 |
| 88 | Oligomenorrhea (HP:0000876) | 1.78707108 |
| 89 | Abnormality of the vocal cords (HP:0008777) | 1.78185662 |
| 90 | Hyperpituitarism (HP:0010514) | 1.73235617 |
| 91 | Back pain (HP:0003418) | 1.71511585 |
| 92 | Tubulointerstitial abnormality (HP:0001969) | 1.71294380 |
| 93 | Hemiplegia (HP:0002301) | 1.71059812 |
| 94 | Abnormality of nucleobase metabolism (HP:0010932) | 1.70463270 |
| 95 | Disproportionate short-trunk short stature (HP:0003521) | 1.69733038 |
| 96 | Coarse facial features (HP:0000280) | 1.65073848 |
| 97 | Myopathic facies (HP:0002058) | 1.65073307 |
| 98 | Macular degeneration (HP:0000608) | 1.64965307 |
| 99 | Ectopia lentis (HP:0001083) | 1.63372861 |
| 100 | Hypothyroidism (HP:0000821) | 1.62693553 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TAOK3 | 3.85185309 |
| 2 | WNK4 | 3.51198065 |
| 3 | TRIB3 | 3.41864834 |
| 4 | MYLK | 3.33761319 |
| 5 | LATS1 | 3.00906908 |
| 6 | SIK1 | 2.59319939 |
| 7 | MST4 | 2.55412180 |
| 8 | LMTK2 | 2.48233511 |
| 9 | AKT3 | 2.45486043 |
| 10 | ERN1 | 2.33460353 |
| 11 | FRK | 2.29197138 |
| 12 | STK38L | 2.17071954 |
| 13 | EPHB1 | 1.75081987 |
| 14 | RIPK1 | 1.71146945 |
| 15 | PKN2 | 1.70471726 |
| 16 | LRRK2 | 1.68489908 |
| 17 | BCKDK | 1.68484389 |
| 18 | PRKD3 | 1.64721934 |
| 19 | LATS2 | 1.63207987 |
| 20 | FER | 1.62576992 |
| 21 | FGFR2 | 1.61337547 |
| 22 | CAMK1D | 1.60900509 |
| 23 | MAP3K6 | 1.60071972 |
| 24 | TTN | 1.56000803 |
| 25 | RET | 1.47268495 |
| 26 | INSRR | 1.35848764 |
| 27 | PDGFRA | 1.33654670 |
| 28 | PTK2 | 1.33073706 |
| 29 | STK38 | 1.31826892 |
| 30 | KSR2 | 1.28191681 |
| 31 | DMPK | 1.23907602 |
| 32 | CAMK1G | 1.23157989 |
| 33 | IRAK3 | 1.21165031 |
| 34 | PAK3 | 1.19465247 |
| 35 | MAP3K2 | 1.18869407 |
| 36 | DDR2 | 1.18494560 |
| 37 | PAK2 | 1.11618783 |
| 38 | MAP2K4 | 1.06485481 |
| 39 | WNK1 | 1.01322820 |
| 40 | ERBB4 | 0.98085048 |
| 41 | PDK3 | 0.94483742 |
| 42 | PDK4 | 0.94483742 |
| 43 | EEF2K | 0.92165331 |
| 44 | FGFR4 | 0.91543309 |
| 45 | STK39 | 0.90995746 |
| 46 | BMX | 0.90951185 |
| 47 | NTRK1 | 0.89939492 |
| 48 | IRAK2 | 0.89582758 |
| 49 | PTK6 | 0.82698620 |
| 50 | NEK1 | 0.82311731 |
| 51 | TYRO3 | 0.80422278 |
| 52 | JAK2 | 0.79596497 |
| 53 | DAPK2 | 0.79593803 |
| 54 | MAP3K4 | 0.75780779 |
| 55 | STK10 | 0.75397871 |
| 56 | EPHB2 | 0.72547282 |
| 57 | TESK1 | 0.70392002 |
| 58 | MAP2K1 | 0.68120268 |
| 59 | PRKCI | 0.68002167 |
| 60 | GRK6 | 0.64086644 |
| 61 | RIPK4 | 0.63817365 |
| 62 | MATK | 0.62505816 |
| 63 | PTK2B | 0.60950251 |
| 64 | PRKCH | 0.60227558 |
| 65 | PAK4 | 0.60170358 |
| 66 | PDK2 | 0.58970887 |
| 67 | OXSR1 | 0.58249764 |
| 68 | EGFR | 0.57048748 |
| 69 | MST1R | 0.56750081 |
| 70 | ERBB2 | 0.56251685 |
| 71 | PHKG2 | 0.55104987 |
| 72 | PHKG1 | 0.55104987 |
| 73 | PRKCZ | 0.54973513 |
| 74 | PDPK1 | 0.52928588 |
| 75 | ILK | 0.50584150 |
| 76 | PIK3CG | 0.49346606 |
| 77 | GSK3A | 0.47963717 |
| 78 | SGK1 | 0.47804019 |
| 79 | IRAK1 | 0.46852467 |
| 80 | MET | 0.46522456 |
| 81 | STK3 | 0.46517862 |
| 82 | DAPK3 | 0.44912212 |
| 83 | INSR | 0.43922511 |
| 84 | MAP3K9 | 0.43916507 |
| 85 | MAPKAPK3 | 0.43889647 |
| 86 | SRC | 0.42235874 |
| 87 | FYN | 0.42067603 |
| 88 | ROCK1 | 0.40962939 |
| 89 | PAK6 | 0.40253864 |
| 90 | TAOK1 | 0.40157160 |
| 91 | PDK1 | 0.38559668 |
| 92 | PRKAA2 | 0.37476941 |
| 93 | TTK | 0.36779377 |
| 94 | PRKD1 | 0.35909628 |
| 95 | DYRK1B | 0.33744039 |
| 96 | JAK1 | 0.33331115 |
| 97 | MTOR | 0.33274477 |
| 98 | PRKAA1 | 0.32392580 |
| 99 | PDGFRB | 0.32116421 |
| 100 | MAP2K2 | 0.32046937 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 3.25628647 |
| 2 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.11120562 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.92832574 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.86278408 |
| 5 | ABC transporters_Homo sapiens_hsa02010 | 2.55435887 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.51040037 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.46660835 |
| 8 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.26487495 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.24644878 |
| 10 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.24615813 |
| 11 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.17506466 |
| 12 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.14903708 |
| 13 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.11137792 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.07529008 |
| 15 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.01408634 |
| 16 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.87286694 |
| 17 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.85713566 |
| 18 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.81284226 |
| 19 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.73053358 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.70949857 |
| 21 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.63800275 |
| 22 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.62056619 |
| 23 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.60445975 |
| 24 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.58997160 |
| 25 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.58173709 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.49138696 |
| 27 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.43660393 |
| 28 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.41542089 |
| 29 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.34289961 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.31915399 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.30616782 |
| 32 | Bile secretion_Homo sapiens_hsa04976 | 1.23407877 |
| 33 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.18412370 |
| 34 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.17469634 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.16923461 |
| 36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.15447818 |
| 37 | Peroxisome_Homo sapiens_hsa04146 | 1.12033626 |
| 38 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.12010307 |
| 39 | Salivary secretion_Homo sapiens_hsa04970 | 1.08803971 |
| 40 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.06529948 |
| 41 | Mineral absorption_Homo sapiens_hsa04978 | 1.06265148 |
| 42 | Carbon metabolism_Homo sapiens_hsa01200 | 1.05592694 |
| 43 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.05250812 |
| 44 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.04256856 |
| 45 | Prion diseases_Homo sapiens_hsa05020 | 1.03878261 |
| 46 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.03104551 |
| 47 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.02098094 |
| 48 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.98861212 |
| 49 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.98718968 |
| 50 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.96758005 |
| 51 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.95865973 |
| 52 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.90120216 |
| 53 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.83079172 |
| 54 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.81871140 |
| 55 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.79696446 |
| 56 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.77760780 |
| 57 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.77620554 |
| 58 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.75593721 |
| 59 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.74119175 |
| 60 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72509193 |
| 61 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.70463432 |
| 62 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.65808886 |
| 63 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.61918371 |
| 64 | Renin secretion_Homo sapiens_hsa04924 | 0.59241841 |
| 65 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.56057560 |
| 66 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.55922340 |
| 67 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.54957898 |
| 68 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52196432 |
| 69 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45318467 |
| 70 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.44359534 |
| 71 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42910206 |
| 72 | Focal adhesion_Homo sapiens_hsa04510 | 0.40285243 |
| 73 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39915396 |
| 74 | Insulin resistance_Homo sapiens_hsa04931 | 0.39345986 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38397536 |
| 76 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.37840659 |
| 77 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.36966494 |
| 78 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.35974020 |
| 79 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35853345 |
| 80 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.35740364 |
| 81 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.33901081 |
| 82 | Lysine degradation_Homo sapiens_hsa00310 | 0.33827970 |
| 83 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.33600791 |
| 84 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.32878527 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.31629900 |
| 86 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.29388923 |
| 87 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.28455592 |
| 88 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.25683057 |
| 89 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.25355639 |
| 90 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.25335473 |
| 91 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.23881978 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.23655594 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.23089927 |
| 94 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.22636296 |
| 95 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.19029328 |
| 96 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.18773610 |
| 97 | Amoebiasis_Homo sapiens_hsa05146 | 0.17600372 |
| 98 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.15765651 |
| 99 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.15184329 |
| 100 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.14963214 |

